Table 3 –
DDE Odds Ratio (OR) | Controlled Variables | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Study + Pub Date; Study Site |
OR (95% CI) |
p-value | Study Conclusion |
None Specified |
Age | Body Weight, Height, and/or BMI |
Pregnancy & Childbirth History |
Lactation | Family History of Breast Cancer or History of BBD |
Other Factors |
Cohn et al.2007; California, USA | 1.00 (.4-2.4) | 0.92 | N.S. | x | xg | |||||
Krieger et al.1994; California, USA | 1.33 (.678-2.61) | 0.43 | N.S. | x | x | x | xabc | |||
Hoyer et al.1998; Denmark | .88 (.563-1.38) | 0.52 | N.S. | x | x | xadel | ||||
Hoyer et al.2000; Denmark | 1.4 (.7-2.8) | - | N.S. | x | x | |||||
Dorgan et al. 1999; Missouri, USA | .8 (.4-1.5) | 0.77 | N.S. | x | ||||||
Wolff et al.1993; New York, USA | 3.68 (1.01-13.5) | 0.04 | S.S. | x | x | x | ||||
Wolff et al.2000p; New York, USA | 1.3 (.51-3.35) | 0.99 | N.S. | x | x | x | x | xb | ||
Hunter et al.1997; USA | .66 (.359-1.215) | 0.47 | N.S. | x | x | x | x | x | xbef | |
Laden et al.2001; USA | .82 (.49-1.37) | 0.15 | N.S. | x | x | x | xb | |||
Iwasaki et al.2008; Japan | 1.48 (.7-3.13) | 0.25 | N.S. | x | x | xabehk | ||||
Raaschou-Nielsen et al.2005; Denmark | .7 (.5-1.2) | 0.29 | N.S. | x | x | x | x | xeg | ||
Unger et al. 1984; Denmark | - | - | - | x | ||||||
Rubin et al.2006; Alaska, USA | 1.43 (.46-4.47) | 0.43 | N.S. | x | x | xci | ||||
Moysich et al.1998; New York, USA | 1.34 (.71-2.55) | 0.25 | N.S. | x | x | x | x | x | ||
Romieu et al.2000; Mexico | 3.81 (1.14-12.8) | 0.02 | S.S. | x | x | x | xbdj | |||
Demers et al.2000b; Quebec, Canada | 1.00 (.6-1.67) | - | N.S. | x | x | x | x | x | xdf | |
van't Veer et al. 1997; Various European Countries | .48 (.25-.95) | 0.02 | S.S. | x | x | x | xef | |||
Liljegren et al.1998; Sweden | .4 (.2-1.2) | - | N.S. | x | x | x | x | x | xe | |
Milikan et al.2000 black; North Carolina, USA | 1.09 (.79-1.51) | - | N.S. | x | x | x | x | xacdg | ||
Milikan et al.2000 white; North Carolina, USA | 1.09 (.79-1.51) | - | N.S. | x | x | x | x | xacdg | ||
Schecter et al.1997; Vietnam | 1.14 (.23-5.68) | - | N.S. | x | ||||||
Lopez-Carrillo et al.1997; Mexico | .76 (.41-1.42) | - | N.S. | x | x | x | x | |||
Wolff et al.2000h; New York, USA | .93 (.56-1.5) | 0.49 | N.S. | x | xac | |||||
Zheng et al.1999; Connecticut, USA | .9 (.5-1.5) | 0.46 | N.S. | x | x | x | x | xabci | ||
Demers et al.2000a; Quebec, Canada | 1.36 (.71-2.63) | - | N.S. | x | x | x | x | x | xd | |
Bagga et al.2000; California, USA | 1.13 (.79-1.60) | 0.5 | N.S. | x | ||||||
Mendonca et al.1999; Brazil | .83 (.4-1.6) | 0.79 | N.S. | x | x | x | x | xdf | ||
Olaya-Contreras et al.1998; Colombia | 1.95 (1.1-3.52) | 0.09 | N.S. | x | x | x | x | xa | ||
Aronson et al.2000; Canada | 1.62 (.84-3.11) | - | N.S. | x | x | xacgh | ||||
Zheng et al.2000; Connecticut, USA | .95 (.68-1.32) | 0.41 | N.S. | x | x | x | x | x | xbcdfh | |
Gatto et al.2007; USA | 1.02 (.61-1.72) | 0.74 | N.S. | x | x | |||||
Gammon et al.2002; New York, USA | 1.2 (.76-1.9) | - | N.S. | x | x | x | xc | |||
Ibarluzea et al.2004; Spain | 1.22 (.677-2.199) | 0.4 | N.S. | |||||||
Stellman et al.2000; New York, USA | .74 (.39-1.247) | 0.3 | N.S. | x | x | xc | ||||
Dello Iacovo et al.1999; Italy | 1.24 (.7-2.2) | - | N.S. | x | x | x | x | xafi | ||
Pavuk et al.2003; Slovakia | 3.04 (.65-14.3) | 0.1 | N.S. | x | xbd | |||||
Ahmed et al.2002; Egypt | - | - | - | x | ||||||
Ahmed et al.2002; Egypt | - | - | - | x | ||||||
Boada et al. 2012; Spain | 0.999 (.996-1.00) | 0.284 | N.S. | x | x | x | xae | |||
Soliman et al.2003 | 1.41 (.63-3.19) | 0.4 | N.S. | x | x | xfi | ||||
Charlier et al.2004; Belgium | 2.21 (1.41-3.48) | 0.0006 | S.S. | x | x | x | xag | |||
Itoh et al.2009; Japan | 1.02 (.46-2.26) | 0.46 | N.S. | x | x | x | x | x | xaehik | |
Waliszewski et al.2005; Mexico (Breast Cancer Cases) | - | x | ||||||||
Waliszewski et al.2005; Mexico (BBD Cases) | x | |||||||||
Siddiqui et al.2005; Delhi, India | - | - | - | x | ||||||
Ociepa-Zawal et al. 2010; Poland | - | - | - | x |
Menopausal status
Age at menarche
Race/Ethnicity; a Education, income, and other socioeconomic metrics; b Smoking and alcohol use; c Geography/study site
Hormone replacement therapy use
Diet
Serum lipid; triglyceride, and/or cholesterol
Presence of other pesticides in sample
Age at menopause
Physical activity
Geometric mean and/or standard deviation
Median